Supporting Commercial Expansion Across EMEA

Inbiome has appointed Gerardas Dambrauskas as its new EMEA Sales Director as the company enters a new phase of commercial growth following IVDR certification of its Molecular Culture® platform.

The company is focused on expanding its commercial footprint across Europe, followed by further growth in the Middle East and Africa.

Scaling Adoption of Molecular Culture®

According to Inbiome, Gerardas will play a key role in supporting partnerships, successful implementations, and the continued expansion of the Molecular Culture® user community.

The company’s Molecular Culture® platform is designed to provide species-level bacterial identification directly from clinical samples while fitting into existing microbiology laboratory workflows.

Experience in Molecular Diagnostics

Gerardas brings experience in building and leading commercial teams within the molecular diagnostics sector.

Inbiome highlighted his hands-on approach and commercial leadership experience as important strengths as the company continues broadening clinical adoption across Europe.

Expanding Clinical Adoption

With increasing interest in rapid molecular diagnostics across clinical microbiology, implementation support and commercial scaling are becoming increasingly important for healthcare providers evaluating new diagnostic workflows.

The appointment reflects Inbiome’s continued focus on supporting adoption of molecular diagnostics in routine clinical practice.